PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Turning Point, Eastern Health, Richmond, VIC 3121, Australia; Monash Alfred Psychiatry Research Centre and Monash Addiction Research Centre, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3004, Australia. Electronic address: Shalini.arunogiri@monash.edu.\', \'Drug and Alcohol Services, South East Sydney Local Health District, NSW Health, Australia; University of Sydney, Addiction Medicine, Faculty of Medicine and Health, Camperdown, NSW 2050, Australia; NSW Drug and Alcohol Clinical Research and Improvement Network, NSW Health, Surry Hills 2010, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0740-5472(20)30478-510.1016/j.jsat.2020.108221
?:doi
?:hasPublicationType
?:journal
  • Journal of substance abuse treatment
is ?:pmid of
?:pmid
?:pmid
  • 33303254
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.311
?:rankingScore_hIndex
  • 91
is ?:relation_isRelatedTo_publication of
?:title
  • Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all